Severity of acute kidney injury is associated with decreased survival after fenestrated and branched endovascular aortic aneurysm repair.
Eric J Finnesgard, Adam W Beck, Matthew J Eagleton...
https://pubmed.ncbi.nlm.nih.gov/37330702/Actively Recruiting
Led by University of Alabama at Birmingham · Updated on 2026-01-06
410
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the safety and effectiveness of three investigational devicesthe Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endograftsin treating complex aortic conditions such as juxtarenal, suprarenal, thoracoabdominal, and aortic arch pathologies that involve at least one brachiocephalic artery or visceral vessels. These devices provide a customized endovascular approach aimed at addressing conditions not treatable with commercially available devices and may reduce hospital stays and complications. Participants will receive one of the three investigational devices based on their specific condition. The Cook Custom Aortic Endograft is designed with up to five fenestrations andor branches to seal and fix the device around affected areas. The Zenith t-Branch Endovascular Graft features four branches connected to key arteries with self-expanding stents. Surgeon-Modified Endografts are created during surgery by adapting existing devices to fit the patients anatomy. Before treatment, participants undergo exams, blood tests, CT scans, X-rays, angiography, and other assessments depending on the aortic pathology. Participants will be followed for five years with regular clinical exams, imaging, neurological assessments, and blood tests to monitor device performance and safety. Researchers will track major adverse events within 30 days post-procedure and monitor mortality rates, pulmonary complications, neurologic morbidity, device integrity, and need for further interventions at multiple time points up to five years. This comprehensive follow-up helps assess the long-term effects and success of these investigational devices in treating complex aortic diseases.
CONDITIONS
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
A
Adam W Beck, MD
R
Rebecca St John
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Alabama at Birmingham
Lead Sponsor
Cook Group Incorporated
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Cook Custom Aortic Endograft | Zenith t‑Branch Endovascular Graft | Surgeon‑Modified Endograft | Open Surgical Repair |
|---|---|---|---|---|
| what it is | A custom‑designed endovascular graft with fenestrations or branches tailored to individual anatomy | A ready‑made branched tubular graft connected to visceral arteries via bridging stents | A commercially available graft modified by surgeons in the operating room with fenestrations or branches | Traditional open surgical replacement of the affected aorta |
| role in trial | One of three investigational arms evaluated in this non‑randomized parallel trial | One of three investigational arms evaluated in this non‑randomized parallel trial | One of three investigational arms evaluated in this non‑randomized parallel trial | Not a trial arm but represents the traditional surgical approach for clinical context |
| primary use | Minimally invasive repair of complex aortic aneurysms in anatomies requiring customization | Endovascular exclusion of aneurysms involving visceral vessels using pre‑configured branched graft | Operative customization of graft to fit complex aortic anatomy in endovascular repair | Definitive open surgical reconstruction for complex aortic aneurysms |
| how it is given or performed | Endovascular placement of a tailored graft with fenestrations or branches under imaging guidance | Endovascular deployment of a branched tubular graft with bridging stents to visceral arteries | Surgeon alters a standard graft during surgery to add fenestrations or branches before endovascular deployment | Open surgical removal of aneurysmal aortic segment and replacement with a prosthetic graft |
| evidence status | Clinical effectiveness is under investigation in this trial; long‑term outcomes not yet established | Clinical effectiveness is under investigation in this trial; long‑term outcomes not yet established | Clinical effectiveness is under investigation in this trial; long‑term outcomes not yet established | Open repair is an established effective treatment for complex aneurysm repair |
| important limitations | Device effectiveness and safety are not proven outside trial settings | Device effectiveness and safety are not proven outside trial settings | Customized grafts may vary by surgeon and lack standardization | Open surgery carries higher perioperative morbidity and recovery time compared with endovascular approaches |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - Procedure day and immediate recovery
Participants undergo placement of one of the aortic endografts (Cook Custom Aortic Endograft, Zenith t-Branch Endovascular Graft, or Surgeon-Modified Endograft) designed to treat their aortic pathology. This includes graft design or sizing based on clinical exams, imaging, and angiography performed during screening.
1 procedure visit (in-person)
Duration - Up to 5 years
Participants are monitored for safety and efficacy outcomes including survival, pulmonary morbidity, device integrity, and need for reintervention after the endograft placement.
Multiple follow-up visits through 5 years after procedure
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Eric J Finnesgard, Adam W Beck, Matthew J Eagleton...
https://pubmed.ncbi.nlm.nih.gov/37330702/Thomas Mesnard, Ying Huang, Andres Schanzer...
https://pubmed.ncbi.nlm.nih.gov/39963789/Victoria J Aucoin, Claire M Motyl, Zdenek Novak...
https://pubmed.ncbi.nlm.nih.gov/37059239/Gustavo S Oderich, Ying Huang, William S Harmsen...
https://pubmed.ncbi.nlm.nih.gov/38989575/University of Alabama at Birmingham
Lead Sponsor
Cook Group Incorporated
Collaborating Sponsor